Results 111 to 120 of about 2,637 (180)

NSUNs-driven dysregulation: the next frontier in targeted cancer therapy? [PDF]

open access: yesCell Death Dis
Zhao Y   +15 more
europepmc   +1 more source

Advancements in antiviral approaches against foot-and-mouth disease virus: a comprehensive review. [PDF]

open access: yesFront Vet Sci
Mohamadin M   +5 more
europepmc   +1 more source

Overcoming Resistance: A Comprehensive Review and Treatment Approach for Acyclovir-Resistant Herpes Simplex Keratitis. [PDF]

open access: yesJ Curr Ophthalmol
Mirzaei A   +8 more
europepmc   +1 more source

[Cancer development after idoxuridine therapy?].

open access: yesTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1983
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Idoxuridine-Induced Conjunctival Cicatrization

Archives of Ophthalmology, 1983
Four patients had idoxuridine-induced conjunctival cicatrization similar to ocular cicatricial pemphigoid develop, but in the treated eye only. Three of the four patients had chronic, recurrent herpes simplex epithelial and stromal keratitis. The fourth patient had Sjögren's syndrome.
J H, Lass, R A, Thoft, C H, Dohlman
openaire   +3 more sources

Idoxuridine-Liposome Therapy for Herpes Simplex Keratitis

American Journal of Ophthalmology, 1981
In the treatment of acute and chronic herpetic keratitis, an idoxuridine-liposome preparation was more effective than a comparable therapeutic regimen of idoxuridine alone. Both antiviral agents were more effective than a control combination of liposome and saline.
G, Smolin   +3 more
openaire   +3 more sources

Trifluorothymidine and Idoxuridine Therapy of Ocular Herpes

American Journal of Ophthalmology, 1977
In a coded study, we treated 40 patients who had active herpes simplex corneal ulcers with either 1% trifluorothymidine (F3T) or 0.1% idoxuridine (IDU) drops; we treated 15 similarly afflicted patients, who had failed on IDU or vidarabine, with open 1% F3T drops. All dosages were at therapeutically recommended frequency. In the coded study there was no
D, Pavan-Langston, C S, Foster
openaire   +3 more sources

Home - About - Disclaimer - Privacy